19.06.2013 - The University of Southern Denmark will host a new centre dedicated to genomics, proteomics and lipidomics analysis and biological network analysis.
The research infrastructure, which gained an €8m funding form the Villum Foundation, will be located at the Center for Bioanalytical Sciences of the university. "The grant is a huge boost to our interdisciplinary research programs in the biological sciences, " said Ole Jensen, who will head the new centre. "It provides us with new equipment to investigate complex biological systems, from individual biomolecules all the way to genomes, proteomes and metabolomes and systems-wide studies."
The centre will incorporate instrumentation for genomics, proteomics and lipidomics studies, and equipment and computers for detailed analysis of biomolecular structures, interactions and networks. "Integration of experimental and computational approaches is essential in modern biological research and this infrastructure grant provides us with a very strong platform for data storage, data integration and computational modelling of biomolecules and cellular networks, to the benefit of SDU researchers and their collaborators", said Jensen.
The University of Southern Denmark is already an established excellence centre for expression proteomics, pushed by funding of Denmark's government in the past.
26.11.2015 Bioeconomy movers and shakers from every corner of the globe met this week at the world’s first Global Bioeconomy Summit in Berlin to discuss, debate and define better ways to ensure the bioeconomy succeeds on an international level.
24.11.2015 After weeks of speculation it is official: US pharma major Pfizer and Irish Botox maker Allergan will merge. With the deal, Pfizer is planning to dodge the high US taxes, causing indignation among US politicians.
23.11.2015 Amidst talk of the IPO window closing and cancelled flotations, diagnostics firms are still striking a chord with investors. Swedish Immunovia and German Curetis are successfully raising public money.
17.11.2015 The first Italian accelerator specifically for biotech projects has been launched with help from Sofinnova Partners. The plan of BiovelocITA: to help Italy grow into one of Europe’s strongest biotech markets.
13.11.2015 Scientists in Bath, UK, have developed a medical dressing that turns fluorescent green when it detects infection. The researchers hope that the smart burns dressing will help fight antibiotic resistance.
13.11.2015 Out with the old: Roche is discarding four sites with 1,200 staff in an effort to restructure its manufacturing network for small molecules. Instead, a new manufacturing site will be built in Switzerland.
10.11.2015 Algae have many skills, but cancer fighting was not one of them – until now. Researchers from Australia and Germany have genetically engineered diatom algae to accurately deliver chemotherapeutic drugs.
10.11.2015 AstraZeneca has plucked Californian biopharma company ZS Pharma from under Actelion’s nose. The UK company is paying US$2.7bn (€2.5bn) to acquire ZS and its promising hyperkalaemia treatment currently under US regulatory review.